It is not a food, drug, cosmetic, or supplement
Its primary role here is to act as a chemical buffer to protect the BPC-157 peptide, not to provide a significant physiological effect of its own
That's the rule, and it doesn't change based on payer
OASIS trials: establishing effective doses Phase 2 OASIS 1 findings: Tested multiple dose levels: 0.3mg, 0.6mg, 1.2mg, 2.4mg, 4.5mg weekly Duration: 26 weeks Primary endpoint: Weight loss at each dose Dose-response results: 0.3mg weekly: ~4% body weight loss 0.6mg weekly: ~6% body weight loss 1.2mg weekly: ~8% body weight loss 2.4mg weekly: ~10% body weight loss 4.5mg weekly: ~12% body weight loss Key insight: Clear dose-response relationship
If youre managing stress, recovering from illness, working through fatigue, or just want a boost, this treatment can be a helpful addition to your routine